- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
UPDATED Jul 03, 2022
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
3 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 603707Nanjing King-Friend Biochemical Pharmaceutical | CNÂ¥28.00 | -4.9% | -10.5% | CNÂ¥34.7b | CNÂ¥31.67 | PE31.1x | E26.6% | 0.5% | ||
| 867China Medical System Holdings | HK$12.24 | -1.9% | -38.7% | HK$30.0b | HK$16.89 | PE8.5x | E8.0% | 4.7% | ||
| ROVILaboratorios Farmaceuticos Rovi | €57.65 | -3.1% | -2.1% | €3.2b | €76.77 | PE17.3x | E10.3% | 1.7% |
Page 1 of 1